|
Volumn 14, Issue 1, 2001, Pages 37-40
|
Ketoconazole and pulmonary failure after esophagectomy: A prospective clinical trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
KETOCONAZOLE;
THROMBOXANE;
THROMBOXANE SYNTHASE INHIBITOR;
ACUTE DISEASE;
ADULT;
AGED;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER RADIOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DISEASE COURSE;
DRUG COST;
DRUG EXPOSURE;
DRUG SAFETY;
ESOPHAGUS CANCER;
ESOPHAGUS RESECTION;
ESOPHAGUS TUMOR;
FEMALE;
HIGH RISK PATIENT;
HUMAN;
INCIDENCE;
LUNG FUNCTION;
LUNG INJURY;
LUNG INSUFFICIENCY;
MALE;
PREMEDICATION;
PRIORITY JOURNAL;
PROPHYLAXIS;
PROSPECTIVE STUDY;
SCORING SYSTEM;
SURGICAL MORTALITY;
THORACOTOMY;
AGED;
ANTIFUNGAL AGENTS;
ESOPHAGEAL NEOPLASMS;
ESOPHAGECTOMY;
FEMALE;
HUMANS;
KETOCONAZOLE;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
RESPIRATORY DISTRESS SYNDROME, ADULT;
RESPIRATORY FUNCTION TESTS;
THROMBOXANES;
|
EID: 0034914611
PISSN: 11208694
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1442-2050.2001.00158.x Document Type: Article |
Times cited : (14)
|
References (15)
|